Diabetes Care Devices & Drugs Market- Global Opportunity Analysis And Industry Forecast (2017-2022)
Global diabetes care devices & drugs market is expected to reach USD 85,591.2 million by 2022, supported by a CAGR of 5.2% during the forecast period of 2017 to 2022. The global diabetes care devices & drugs market is mainly driven by the increasing incidence & prevalence of diabetes, technological advancements, rising obesity rate, and increasing sedentary lifestyle & improper diet. However, high cost associated with diagnosis and treatment, reimbursement issues, and lack of awareness is expected to hinder the growth of diabetes care devices & drugs market to some extent. Developments of new formulations and insulin delivery technologies serve as an opportunity for this market, whereas stringent regulations and registration process for the diabetes care devices & drugs poses significant challenge for the growth of diabetes care devices & drugs market.
The global diabetes care devices & drugs market is mainly segmented by type of devices and drugs. The diabetes care devices market by type is further segmented into diabetes monitoring devices and insulin delivery devices. The drugs market by type is further segmented into insulin, oral-hypoglycemic agents, and non-insulin injectable. Diabetes care drugs market dominated the overall market in 2016, and is expected to grow significantly in the next 5-10 years. The large share of this market is mainly attributed to the huge demand for insulin and oral hypoglycemic drugs for the treatment of type I & II diabetes.
Geographically, the global diabetes care devices & drugs market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global diabetes care devices & drugs market in 2016, followed by Europe, and Asia-Pacific. The major share of the North America is mainly attributed to the large & growing base of diabetic patients, well-established healthcare infrastructure, higher adoption of technologically innovative diabetic care products, increasing research on diabetes, and presence of large number of leading players in the market. However, Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increasing greying population, rising burden of diabetic population, various government initiatives to increase the awareness & prevention of diseases, and increasing sedentary lifestyles in developing countries such as India, & China.
The key players in the global diabetes care devices & drugs market are Novo Nordisk A/S, Ypsomed AG, Abbott, Ascensia Diabetes Care Holdings AG, Eli Lilly and Company, Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, Sanofi S.A., Merck & Co., Inc., Novartis AG, AstraZeneca PLC, and Boehringer Ingelheim GmbH.
Scope of the Report
Market by type
Diabetes care devices market by Type
Diabetes monitoring devices
Continuous Blood Glucose Monitoring Devices
Haemoglobin A1c Testing Kits
Insulin delivery devices
Insulin Jet Injectors
Diabetes care drugs market by Type
Rapid acting Insulin
Short acting Insulin
Intermediate acting Insulin
Long acting Insulin
Meglitinide / Phenylalanine analogues
Dipeptidyl peptidase -4 (DPP-4) inhibitor
Non-insulin injectable drugs
Market by Geography
Rest of Europe
Rest of Asia-Pacific
Rest of World
Middle East & Africa
Key questions answered in the report-
Which are the high growth market segments in terms of type and regions/countries?
What is the historical market for diabetes care devices & drugs across the globe?
What are the market forecasts and estimates from the period 2015-2022?
What are the major drivers, challenges, opportunities, and trends in the global diabetes care devices & drugs market?
Who are the major players in the global diabetes care devices & drugs market and what share of the market do they hold?
Who are the major players in various countries and what share of the market do they hold?
What are the competitive landscapes and who are the market leaders by sub-region in the global diabetes care devices & drugs market?
What are the recent developments in the global diabetes care devices & drugs market?
What are the different strategies adopted by the major players in the global diabetes care devices & drugs market?
What are the geographical trends and high growth regions/ countries?
Who are the local emerging players in the global diabetes care devices & drugs market and how do they compete with the global players?